Presentation is loading. Please wait.

Presentation is loading. Please wait.

Volume 385, Issue 9975, Pages (April 2015)

Similar presentations


Presentation on theme: "Volume 385, Issue 9975, Pages (April 2015)"— Presentation transcript:

1 Volume 385, Issue 9975, Pages 1295-1304 (April 2015)
Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo- controlled trial  Prof David F Garway-Heath, MD, Prof David P Crabb, PhD, Catey Bunce, DSc, Gerassimos Lascaratos, MSc, Francesca Amalfitano, BSc, Nitin Anand, MD, Prof Augusto Azuara-Blanco, PhD, Prof Rupert R Bourne, MD, David C Broadway, MD, Ian A Cunliffe, FRCOphth, Jeremy P Diamond, PhD, Scott G Fraser, MD, Tuan A Ho, PhD, Prof Keith R Martin, DM, Andrew I McNaught, MD, Anil Negi, MD, Krishna Patel, MSc, Richard A Russell, PhD, Ameet Shah, MRCOphth, Paul G Spry, PhD, Katsuyoshi Suzuki, PhD, Edward T White, BSc, Richard P Wormald, FRCOphth, Wen Xing, MSc, Prof Thierry G Zeyen, PhD  The Lancet  Volume 385, Issue 9975, Pages (April 2015) DOI: /S (14) Copyright © 2015 Garway-Heath et al. Open Access article distributed under the terms of CC BY Terms and Conditions

2 Figure 1 Study profile IOP=intraocular pressure. VF=visual field. Four patients who did not fulfil the eligibility criteria were randomised. Two did not attend any post-baseline visits (both in the latanoprost group). Of the remaining two, one was analysed in the latanoprost group and one in the placebo group. The Lancet  , DOI: ( /S (14) ) Copyright © 2015 Garway-Heath et al. Open Access article distributed under the terms of CC BY Terms and Conditions

3 Figure 2 Kaplan-Meier failure estimates for visual field progression
The Lancet  , DOI: ( /S (14) ) Copyright © 2015 Garway-Heath et al. Open Access article distributed under the terms of CC BY Terms and Conditions

4 Figure 3 IOP over trial period
IOP in patients under follow-up (A) and in all patients with last observation carried forward for patients no longer under follow-up (B). IOP is given for the eye with the worst visual field MD. Error bars represent the 95% CI around the mean. IOP=intraocular pressure. *Baseline visit at −6 weeks, excluding those who did not attend at 0 months. The Lancet  , DOI: ( /S (14) ) Copyright © 2015 Garway-Heath et al. Open Access article distributed under the terms of CC BY Terms and Conditions

5 Figure 4 Change from baseline in visual field MD at the time of the primary end point (A) Shows median (horizontal bar), IQR (shaded box), 1·5-times the IQR (whiskers), and outliers (open circles). (B) Scatterplot of baseline MD versus MD at endpoint. MD=mean deviation. The Lancet  , DOI: ( /S (14) ) Copyright © 2015 Garway-Heath et al. Open Access article distributed under the terms of CC BY Terms and Conditions


Download ppt "Volume 385, Issue 9975, Pages (April 2015)"

Similar presentations


Ads by Google